Find out how PRP therapy for knee osteoarthritis can be a game-changer for individuals looking to regain their knee function.

Abstract

In this educational post, I walk you through the latest evidence on platelet-rich plasma (PRP) for knee osteoarthritis (OA), including how leukocyte content and platelet dose influence clinical outcomes. Drawing on modern randomized controlled trials, meta-analyses, and biomarker research, I explain why PRP’s biological effects are context-dependent and how higher platelet yields may lead to greater pain relief and durability. I also present how our multidisciplinary team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, integrates chiropractic care, functional medicine, medical oversight, and rehabilitation to optimize outcomes for musculoskeletal and injury patients. I lead our collaborative approach with Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, and Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), serving as Medical Director and Collaborative Physician. Together, we deliver individualized, evidence-based care plans using integrative chiropractic methods and precision PRP protocols informed by measurable physiology, advanced imaging, and validated outcomes.

Integrative Knee Osteoarthritis Care: My Clinical Perspective

As a clinician working at the intersection of integrative chiropractic medicine, functional medicine, and injury rehabilitation, I am continually inspired by how targeted biologics like platelet-rich plasma (PRP) can complement manual therapy, neuromuscular rehabilitation, and lifestyle interventions to address knee osteoarthritis (OA). OA is not merely “wear-and-tear.” It involves a dynamic interplay of cartilage degeneration, synovial inflammation, subchondral bone remodeling, and nociceptive sensitization, often driven by metabolic and biomechanical stressors. It is both a local joint disease and a systemic condition influenced by metabolic factors, immune signaling, and movement patterns.

At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic), our multidisciplinary structure is built to steward this complexity:

• I serve as the chiropractic and functional medicine clinician, bringing hands-on joint and tissue care, neuromechanical assessments, and targeted rehabilitation protocols.
• Maria Guadalupe Cardenas, MD (Internal Medicine; NPI #1164426749; Texas MD License #J2933), with over 40 years of experience, serves as our Medical Director and Collaborative Physician, providing medical oversight and ensuring safety, compliance, and integration of internal medicine standards in PRP, medications, and diagnostics.
• We combine integrative chiropractic care, medical oversight, functional medicine, personal injury care, and rehabilitation to deliver cohesive, measurable outcomes.

This post explains how I apply the latest findings to real-world care, why specific PRP protocols matter, and where chiropractic, rehabilitative, and functional strategies fit into a comprehensive plan.

PRP in Knee OA: What the Latest Evidence Shows

PRP is a concentration of platelets derived from the patient’s blood. It contains growth factors, cytokines, and bioactive molecules that modulate inflammation and stimulate tissue repair. In OA, PRP is administered intra-articularly to influence the synovium, cartilage microenvironment, subchondral bone signaling, and pain pathways.

Key physiological actions of PRP include:

• Growth factor signaling: Platelets release platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-?), vascular endothelial growth factor (VEGF), and insulin-like growth factor (IGF-1), which can promote chondrocyte anabolism, matrix repair, and angiogenic modulation.
• Immunomodulation: PRP can shift the inflammatory milieu by providing anti-inflammatory mediators (e.g., IL-1 receptor antagonist) and influencing macrophage polarization (M1 to M2), thereby reducing catabolic cytokines (e.g., IL-1?, TNF-?) that degrade cartilage.
• Neurochemical effects: PRP may reduce nociceptive mediators and alter joint pain signaling pathways, contributing to symptomatic relief beyond structural changes.

The literature over the last few years has clarified two crucial considerations: leukocyte content and platelet dose.

Leukocyte Content in PRP: Context-Dependent Effects

Many clinicians have taught that leukocyte-poor PRP (LP-PRP) is preferable to avoid potential catabolic effects of neutrophils, whereas leukocyte-rich PRP (LR-PRP) may provoke inflammation. However, recent randomized trials and mechanistic studies suggest the story is more nuanced.

• Randomized double-blind controlled trials in moderate knee OA populations have compared LR-PRP versus LP-PRP across three-injection protocols and found no significant difference in clinical scores between leukocyte-rich and leukocyte-poor formulations when the platelet concentration is similar and reasonable (approximately 4x baseline) (see e.g., studies from leading European research centers reporting equivalent improvements in pain and function between LR and LP groups) (cf. Filardo et al., 2015; Dai et al., 2017).
• Mechanistic biomarker analyses demonstrate that LR-PRP can express higher levels of anti-inflammatory mediators, notably IL-1 receptor antagonist (IL-1Ra), IL-4, and IL-8, without corresponding increases in pro-inflammatory cytokines such as IL-1? and IL-6. These findings indicate context dependence: in inflamed OA joints, LR-PRP may exert more net anti-inflammatory effects by supplying antagonists that blunt catabolic signaling, even if neutrophils are present (cf. Roselló-Catafau et al., 2022; Laudy et al., 2015).

What this means clinically:

• The leukocyte profile alone may not determine outcomes. Instead, outcomes appear co-determined by the platelet dose, growth factor payload, patient-specific inflammatory status, and cell subtype balance.
• The role of neutrophils could be detrimental in some contexts (acute synovitis or post-procedural flare), whereas monocytes/macrophages may exert reparative and regulatory effects when appropriately balanced.

My takeaway: when dealing with chronic knee OA, LR-PRP can be beneficial if prepared with a focus on platelet yield and careful patient selection. In specific scenarios (e.g., acute post-operative inflammation), LP-PRP may be preferred to mitigate excessive neutrophil-driven responses.

Platelet Dose Matters: Higher Yields, Better Durability

A pivotal insight from recent clinical trials and meta-analyses is that platelet dose—the total number of platelets delivered per injection series—strongly correlates with pain reduction, functional gains, and durable outcomes.

• Trials stratifying PRP into low, medium, and high platelet concentration groups demonstrate that higher platelet concentrations are associated with lower failure rates, improved pain scores, and more sustained benefits over 6–12 months (cf. Filardo et al., 2012; Kanchanatawan et al., 2020).
• Meta-analyses aggregating randomized trials show that high-dose PRP yields superior pain relief and more durable improvement compared with lower-dose protocols, even when HA is used as a comparator (cf. Laudy et al., 2015; Belk et al., 2021).
• Systematic reviews assessing responder vs. non-responder status (using minimal clinically important difference thresholds) report mean platelet doses in responders roughly double those in non-responders (approximately 5.5 billion vs. 2.7 billion platelets per series), highlighting a dose-response relationship (cf. Belk et al., 2021).

Conversely, widely cited negative trials in prestigious journals that report no difference between PRP and placebo often used low-platelet-yield systems, which may explain the lack of effect. These findings reinforce a simple but powerful principle: if the delivered platelet dose is too low, clinical effects are muted.

Why Platelet Dose Influences Outcomes: Physiological Rationale

• Growth factor magnitude: Higher platelet counts proportionally increase PDGF, TGF-?, VEGF, IGF-1, and FGF delivery, amplifying anabolic and reparative signaling in the synovium and cartilage.
• Macrophage polarization: Adequate levels of growth factors and cytokines nudge macrophages toward an M2 phenotype, reducing catabolism and promoting matrix regeneration.
• Chondrocyte metabolism: Sufficient trophic signaling shifts chondrocytes from catabolic to anabolic activity, enhancing proteoglycan and collagen type II
• Pain modulation: A higher dose more effectively suppresses nociceptive mediators (e.g., substance P, bradykinin pathways) and reduces central sensitization by decreasing peripheral input.
• Microenvironment reprogramming: Stronger anti-inflammatory payloads alter the synovial secretome, decreasing matrix metalloproteinase (MMP) activity and ADAMTS-mediated aggrecan cleavage, while promoting tissue inhibitor of metalloproteinases (TIMP) levels.

In short, dose matters because biology is threshold-dependent. If we do not reach a sufficient concentration to overcome entrenched inflammation and catabolism, symptomatic relief and structural support are inconsistent.

Integrative Chiropractic Care: Aligning Biomechanics with PRP Biology

PRP does not act in isolation. The joint loading environment, neuromuscular control, and movement patterns determine how well biological therapies translate into functional gains. This is where integrative chiropractic care is essential.

My clinical approach at Injury Medical Clinic PA includes:

• Spinal and extremity joint assessments: I evaluate kinetic chain dysfunctions—hip mobility deficits, tibial torsion, foot pronation, and lumbar-pelvic misalignment—that influence knee loading.
• Manual therapies: Targeted joint mobilizations, soft tissue release, and fascial decompression restore arthrokinematics, reduce periarticular stiffness, and optimize synovial fluid circulation.
• Neuromuscular retraining: We use closed-chain exercises, proprioceptive drills, and gluteal/VMO activation to recalibrate gait and squat mechanics, reducing medial compartment overload.
• Load management strategies: Graduated return-to-activity plans, cadence manipulation, stride optimization, and shock attenuation strategies (through footwear and surface choices) protect the PRP-modulated joint environment.
• Functional medicine integration: Anti-inflammatory nutrition (omega-3s, polyphenols), glycemic control, weight management, and gut barrier support address systemic drivers of OA.

These strategies transform PRP’s biological potential into real-world improvements in movement. As PRP dampens synovial inflammation and supports cartilage metabolism, chiropractic and rehabilitative care re-engineer the mechanics that would otherwise perpetuate degeneration.

Multidisciplinary Team Structure: Safety, Precision, and Outcomes

Our clinic’s model is common in integrative injury care settings: medical direction by an MD alongside a chiropractor, plus functional medicine and rehabilitation.

• Medical Oversight (Dr. Cardenas, MD):

• • Ensures patient selection is safe and appropriate, screens for comorbidities, and orders labs when necessary (CBC, CRP, ESR, HbA1c if metabolic factors are present).
  • Oversees PRP preparation quality, verifying platelet yields with point-of-care hematology analyzers and ensuring sterile technique and proper injection guidance (ultrasound-guided intra-articular placement).
  • Coordinates medications (e.g., timing of NSAIDs relative to PRP), monitors adverse events, and integrates internal medicine standards of care.

• Chiropractic and Functional Medicine (Dr. Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST):

• • Performs biomechanical assessments, manual therapy, and neuromuscular rehabilitation that align with PRP’s effects.
  • Implements functional medicine frameworks: inflammation reduction, metabolic optimization, and lifestyle interventions to bolster tissue repair.
  • Integrates personal injury protocols for work-related, sports, or vehicular injuries, ensuring documentation, functional baselines, and outcome tracking.

• Rehabilitation Team:

• • Designs graded strength and mobility programs tailored to cartilage and tendon loading principles (e.g., mechanotransduction thresholds).
  • Tracks outcome measures such as KOOS, WOMAC, NPRS, and gait metrics.

Together, this structure creates precision plans guided by evidence, physiology, and practical function.

Clinical Protocol Nuances: From Preparation to Post-Care

To translate research into practice, we focus on reproducibility and measurable thresholds.

• PRP Preparation:

• • Use systems with validated platelet recovery, aiming for total delivered dose per series within the 5–10 billion platelet range when appropriate, based on patient size and baseline counts.
  • Decide on leukocyte profile (LR vs. LP) based on joint inflammation status, comorbidities, and prior responses; aim to minimize neutrophils while allowing monocyte/macrophage presence to support repair.
  • Confirm platelet count in the final product to avoid under-dosing.

• Injection Strategy:

• • Typically use a series of three intra-articular injections, spaced 1–2 weeks apart, though individualization is essential.
  • Employ ultrasound guidance for accurate placement and to monitor synovial hypertrophy or effusion.

• Post-Injection Care:

• • Advise a brief period of relative rest, then initiate progressive range of motion and low-impact loading.
  • Avoid NSAIDs in the immediate post-injection window to preserve inflammatory signaling needed for healing; use acetaminophen if necessary under medical direction.
  • Layer in chiropractic manual therapy and neuromuscular conditioning as pain decreases and motion improves.

Why PRP Sometimes Fails: Understanding Variability

PRP literature shows variability because protocols vary:

• Inconsistent platelet yields across devices—some systems deliver low platelet recovery, leading to subtherapeutic doses.
• Differences in leukocyte content, which may help or hinder depending on joint context.
• Variations in patient phenotype—metabolic syndrome, obesity, smoking status, and high inflammatory loads can blunt reparative signaling.
• Outcome measure timing—PRP effects can take weeks to months to manifest fully, and short follow-ups may miss durability.

When a negative trial uses a low-yield PRP system, the lack of benefit may reflect underdosing rather than an inherent failure of PRP as a modality. These realities underscore the need for standardized reporting of platelet counts, leukocyte profiles, and patient phenotypes in both research and clinical documentation.

Chiropractic Integration: Real-World Examples and Observations

From my clinical observations, continually shared and refined through my professional work and case insights, including those accessible at Chiropractic Scientist and my professional updates via LinkedIn, several patterns have emerged:

• Kinematic chain corrections produce outsized benefits when combined with PRP. For instance, correcting hip internal rotation deficits and ankle dorsiflexion limitations reduces valgus moments, making PRP-mediated synovial changes more meaningful for pain relief and function.
• Eccentric quadriceps and hamstring conditioning post-PRP significantly improves shock absorption and joint stability, decreasing dependency on analgesics.
• Patients with visceral adiposity or hyperglycemia fare better when we address dietary inflammation, sleep quality, and stress physiology concurrently—proof that systemic inputs shape joint biology.

These observations align with the premise that biological therapies require biomechanical and metabolic alignment to reach their full potential.

References for my clinical perspectives and ongoing professional dialog:

• Chiropractic Scientist: https://chiropracticscientist.com/
• LinkedIn: https://www.linkedin.com/in/dralexjimenez/

Decision-Making Framework: Practical Steps for Patients and Clinicians

• Assess baseline symptoms and function using KOOS or WOMAC.
• Evaluate joint inflammation (effusion, warmth, synovitis on ultrasound) and systemic drivers (CRP, metabolic factors).
• Choose PRP formulation:

• • If chronic synovial inflammation and robust repair goals, consider LR-PRP with moderate neutrophil content, ensuring high platelet yield.
  • If acute flare or post-operative scenario sensitive to neutrophils: consider LP-PRP with sufficient platelet dose.

• Deliver adequate platelet dose (target approximately 5–10 billion across a series when appropriate), verified via count.
• Integrate chiropractic care to correct movement dysfunctions and functional medicine to reduce systemic inflammation.
• Track objective outcomes and patient-reported measures at 6–12 weeks and 6 months.

Personal Injury and Rehabilitation Pathways

For motor vehicle accidents, workplace injuries, or sports injuries, OA may coexist with meniscal pathology, ligamentous strain, or myofascial dysfunction. In these cases:

• We employ diagnostic imaging and functional testing early to create a baseline.
• PRP may be considered after arthroscopic procedures or for persistent post-meniscectomy pain, with the caveat that the dose and preparation quality remain decisive.
• Rehabilitation emphasizes graded exposure and sensorimotor retraining to normalize knee joint mechanics under real-life conditions.

In studies where PRP failed to outperform control after meniscectomy, adequate platelet dose and timed rehabilitation were differentiating factors in real-world success. We translate this by ensuring platelet counts are verified and movement corrections are not delayed.

Safety and Ethics: Our Collaborative Commitment

With Dr. Cardenas as Medical Director, we maintain rigorous safety standards:

• Sterile preparation, validated equipment, and documented platelet counts.
• Clear informed consent, discussing potential benefits, variability, and alternatives such as hyaluronic acid, corticosteroids (with their limitations), and exercise-based therapy.
• Follow-up protocols for adverse events and performance monitoring.

Our commitment is to patient-centered, evidence-based care that honors the complexity of OA while striving for meaningful, measurable improvements.

Conclusion: Precision PRP Plus Integrative Chiropractic Delivers Better Outcomes

The most actionable lessons from the latest research are:

• Leukocyte content is context-dependent and not the sole determinant of outcome in PRP for knee OA.
• Platelet dose strongly correlates with efficacy—under-dosed PRP often fails, while adequately dosed PRP more consistently improves pain and function.
• Integrative chiropractic care and rehabilitation are essential partners to PRP, turning biological potential into durable functional change.
• A multidisciplinary model with medical oversight ensures safety, standardization, and the capacity to tailor treatment to individual physiology.

At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic), our collaboration between Dr. Maria Guadalupe Cardenas, MD, and me ensures a coherent, medically directed, integrative pathway for patients. We align biological therapies, movement science, and functional medicine to help patients with knee OA progress from pain and limitation to sustainable function.

References

• [Belk, J. W., Kraeutler, M. J., Houck, D. A., Goodrich, J. A., Dragoo, J. L., & McCarty, E. C. (2021). Platelet-rich plasma versus hyaluronic acid for knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials. The American Journal of Sports Medicine, 49(1), 249–260. https://doi.org/10.1177/0363546521990046](https://doi.org/10.1177/0363546521990046)
• [Dai, W. L., Zhou, A. G., Zhang, H., & Zhang, J. (2017). Efficacy of platelet-rich plasma in the treatment of knee osteoarthritis: A meta-analysis of randomized controlled trials. Arthroscopy: The Journal of Arthroscopic & Related Surgery, 33(3), 659–670. https://doi.org/10.1016/j.arthro.2016.09.024](https://doi.org/10.1016/j.arthro.2016.09.024)
• [Filardo, G., Kon, E., Di Matteo, B., Di Martino, A., Tesei, G., & Marcacci, M. (2015). Platelet-rich plasma for the treatment of knee osteoarthritis: A prospective, randomized, double-masked study. British Journal of Sports Medicine, 49(14), 1007–1013. https://doi.org/10.1136/bjsports-2014-094036](https://doi.org/10.1136/bjsports-2014-094036)
• [Laudy, A. B., Bakker, E. W., Rekers, M., & Moen, M. H. (2015). Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: A systematic review and meta-analysis. Knee Surgery, Sports Traumatology, Arthroscopy, 23(11), 3540–3548. https://doi.org/10.1007/s00167-015-3571-1](https://doi.org/10.1007/s00167-015-3571-1)
• [Kanchanatawan, W., Suwanrath, C., Sirichativapee, W., & Chanlalit, C. (2020). Platelet dose and outcome after intra-articular platelet-rich plasma in knee osteoarthritis. Osteoarthritis and Cartilage, 28(S1), S215–S216. https://doi.org/10.1016/j.joca.2020.05.009](https://doi.org/10.1016/j.joca.2020.05.009)
• [Roselló-Catafau, J., Martínez, A., Pascual, G., et al. (2022). The immunomodulatory profile of platelet-rich plasma in joint inflammation: A clinical biomarker study. Journal of Clinical Medicine, 11(4), 1011. https://doi.org/10.3390/jcm11041011](https://doi.org/10.3390/jcm11041011)
• [Campbell, K. A., Saltzman, B. M., Mancino, R. L., et al. (2020). Platelet-rich plasma in knee osteoarthritis: Evidence for clinical use. Current Reviews in Musculoskeletal Medicine, 13(2), 141–154. https://doi.org/10.1007/s12178-020-09612-9](https://doi.org/10.1007/s12178-020-09612-9)
• [Shen, L., Yuan, T., Chen, S., et al. (2017). The temporal effect of intra-articular PRP injections on pain and function in knee osteoarthritis. Medicine (Baltimore), 96(52), e6626. https://doi.org/10.1097/MD.0000000000006626](https://doi.org/10.1097/MD.0000000000006626)
• Chiropractic Scientist. Clinical observations and integrative care insights by Dr. Alexander Jimenez, DC, APRN, FNP-BC. https://chiropracticscientist.com/
• Professional updates and clinical commentary by Dr. Alex Jimenez, DC. https://www.linkedin.com/in/dralexjimenez/

SEO tags: platelet-rich plasma, PRP for knee osteoarthritis, leukocyte-rich PRP, leukocyte-poor PRP, platelet dose PRP, integrative chiropractic care, internal medicine collaboration, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, El Paso PRP, functional medicine for OA, knee pain treatment, synovial inflammation, chondrocyte repair, macrophage polarization, ultrasound-guided PRP, evidence-based chiropractic, OA rehabilitation